CN107812021A - A kind of method that saikoside is extracted from radix bupleuri - Google Patents

A kind of method that saikoside is extracted from radix bupleuri Download PDF

Info

Publication number
CN107812021A
CN107812021A CN201711146228.1A CN201711146228A CN107812021A CN 107812021 A CN107812021 A CN 107812021A CN 201711146228 A CN201711146228 A CN 201711146228A CN 107812021 A CN107812021 A CN 107812021A
Authority
CN
China
Prior art keywords
saikoside
radix bupleuri
broken wall
ethyl alcohol
absolute ethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201711146228.1A
Other languages
Chinese (zh)
Inventor
朱念
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Qinzhou University
Original Assignee
Qinzhou University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qinzhou University filed Critical Qinzhou University
Priority to CN201711146228.1A priority Critical patent/CN107812021A/en
Publication of CN107812021A publication Critical patent/CN107812021A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/233Bupleurum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10Preparation or pretreatment of starting material
    • A61K2236/15Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10Preparation or pretreatment of starting material
    • A61K2236/17Preparation or pretreatment of starting material involving drying, e.g. sun-drying or wilting
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50Methods involving additional extraction steps
    • A61K2236/51Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50Methods involving additional extraction steps
    • A61K2236/53Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50Methods involving additional extraction steps
    • A61K2236/55Liquid-liquid separation; Phase separation

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to a kind of method that saikoside is extracted from radix bupleuri.The present invention is that fresh radix bupleuri root is dried into radix bupleuri medicine materical crude slice, then a broken wall is carried out with wall-breaking machine, secondary broken wall is carried out with high pressure purified air cutting mill, radix bupleuri powder sodium acetate solution and absolute ethyl alcohol after broken wall extract saikoside and go the removal of impurity, obtained saikoside crude extract is refined by preparative high performance liquid chromatography instrument again, finally obtains saikoside powder by vacuum freeze drying.The present invention is using the technique that the cell progress broken wall of radix bupleuri is first extracted into saikoside again, cell-wall breaking ratio is up to 99.4%, saikoside recovery rate is up to more than 92%, low temperature broken wall and gentle extracting method, it can effectively avoid the chemical constitution of saikoside from changing, ensure the good pharmaceutical activity of saikoside.

Description

A kind of method that saikoside is extracted from radix bupleuri
Technical field
Technical field of natural product extraction of the present invention, more particularly, to a kind of method that saikoside is extracted from radix bupleuri.
Background technology
Radix bupleuri, smoke, mountain dish, mushroom grass, faggot alias, be《Chinese Pharmacopoeia》The herbal medicine included, medicinal part are Umbelliferae The dry root of plant radix bupleuri or radix bupleuri scorzoneraefolii.Radix bupleuri is bitter in taste, is slightly cold, Return liver, gallbladder channel, have with inducing diaphoresis, the work(of soothing the liver rising Yang Effect, for cold, fever, fevers and chills alternate, malaria, stagnation of QI due to depression of the liver, sternal rib pain, prolapse of the anus, the prolapse of uterus, irregular menstruation.
Saikoside structure is pentacyclic triterpene oleanane type derivative, and its aglycon is divided into 7 kinds of different types:Epoxy Ether (I), different ring diene (II), 12- alkene (III), with ring diene (IV), 12 alkene -28- carboxylic acids (V), different ring diene -30- carboxylic acids (VI), 18- ene-type (VII).Typically containing only glucose, furan sugar, rhamnose and xylose in saikoside, in addition, removing any of the above sugar There is pentitol (pentitol) outside.Up to now, have studied more than 20 kinds of radix bupleuri of the category altogether, from Bupleunim. L it is separated go out 90 A variety of saponin components, it was found that more than 30 kinds of noval chemical compound.It is 43 to separate within nearly 10 years the saponin(e identified, document report is more It is saikosaponin a, b, c, d etc., saponin(e is mostly to get from radix bupleuri root, and the saponin(e that aerial part is got is few.
Various types of saikoside all has important pharmacological action:Saikosaponin a significantly inhibits Adenosine triphosphate The platelet aggregation that glycosides induces, it is suitable with aspirin effect, and endogenous arachidonic acid generation blood is suppressed with dose-dependant Bolt element.Saikosaponin a, d have the researchs such as class cyclopentanoperhydro-phenanthrene spline structure, Dobashi discovery:To Mouse oral saikoside 0.2~2.0 Find that the corticotropin (ACTH) in serum substantially increases after mg/kg, and ACTH precursors, inferior colliculus in adenohypophysis The level of corticotropin generation hormone (CRF) mRNA in brain also substantially increases, and is in dose dependent, and radix bupleuri Saponin(e a is but without this effect.Chiang LC etc. observe saikosaponin a, c, d work using the human hepatocarcinoma cells of HBV transfections With discovery, saikoside c can substantially suppress the expression of HbeAg in culture medium, and HBV-DNA duplication has also obtained effective suppression, Prompting saikoside can prevent conversion of the hepatitis B to liver fibrosis.In anti-GBM type ephritis and Heymann kidneys In scorching rat model, saikoside d can mitigate Urine proteins, reduce blood fat in 2 disease early stage, late period stage administrations, discovery, Mitigate glomerulus pathological change;IgG, C3 deposition substantially reduce compared with control group in glomerulus;Corticotrophins in serum Glucocorticoid receptor (GR) has increased in element, cortisone, nephridial tissue.Prompt saikoside d may be by stimulating HPA Axle, strengthen the function of glucocorticoid, suppress the generation of the metabolites such as arachidonic acid, so as to inhibit the generation of inflammation. Saikosaponin a, d, f can increase mouse T, the activity of bone-marrow-derived lymphocyte and the secretion level of interleukins -2 (IL-2), radix bupleuri Saponin(e a, d can also make the horizontal raising of IgA, IgG, IgM in blood plasma, most strong with saikoside d activity.Under saikoside d effect, The autgmentability of macrophage, activity of acid phosphatase, chemiluminescence etc. are in dose dependent increase.Motoo Y etc. have studied bavin Hu saponin(e different component is to liver, the effect of pancreatic tumor cell, it is found that when tumor cell of liver 50% suppresses, saikoside d concentration is 20 mg/mL, the concentration of saikosaponin a is 50 mg/mL, saikoside b2, c> 1 000 mg/mL.The mg/ of saikosaponin a 50 ML can suppress the growth of this 2 kinds of tumour cells and DNA synthesis.Chiang LC etc. research also found that saikoside d passes through work Change Caspase3, Caspase7 induction HepG2 Human liver tumor's Apoptosis, so as to realize antineoplastic action.Tsai YJ etc. Broken up with saikosaponin a, b1, b2, c, d inducing mouse C6 glioma cells.Saikosaponin a, d propagation capable of inhibiting cell, change Cellular morphology, and saikosaponin a can significantly inhibit the activity of glutamine synthelase and cyclic nucleotide hydrolase.
The method for extracting saikoside from radix bupleuri at present is all without breaking-wall cell, directly using seepage pressure effects or is carried The method for taking tank to extract.Chinese patent CN201210595558.X(Application number)Disclose one kind and radix bupleuri is prepared from bigleaf thorowax root The method of saponin(e, this method comprise the following steps:(1) radix bupleuri raw material is ground into after coarse powder and adds continuous countercurrent extracting tank with third Ketone aqueous solution refluxing extraction;(2) extract solution that will be handled through (1) filters, and obtains saikoside crude extract;(3) by gained radix bupleuri soap Glycosides crude extract concentrates, and obtains the thick concentrate of saikoside;(4) the thick concentrate of gained saikoside is pumped into continuous extraction filling group material Tank, extractant are ethyl acetate, and saikoside acetic acid ethyl acetate extract is obtained via extraction tower;(5) by saikoside acetic acid second Ester extract concentrates, and obtains saikoside condensed cream;(6) saikoside condensed cream is mixed into silica gel, and by the mixture mixed as Above silicagel column, eluted through ethyl acetate and petroleum ether mixed liquor, obtain eluent;(7) will be concentrated after eluent recycling design dry It is dry to obtain saikoside semi-finished product;(8) saikoside semi-finished product are dissolved with aqueous acetone solution, filtered, reclaimed acetone, concentration, put Precipitation crystal is put, filters to obtain saikoside finished product.The radix bupleuri of this method does not pass through breaking-wall cell, employs aqueous acetone solution Refluxing extraction, it is also necessary to the step such as concentrated, extracted, during that acetone, ethyl acetate, petroleum ether etc. is used for multiple times is organic Solvent, easily cause pollution and the residual of organic solvent.Chinese patent CN201610570811.4(Application number)Disclose one kind The extracting method of saikoside, including:Step 1:Radix Bupleuri is crushed to 40~60 mesh;Step 2:It is with pH value by radix bupleuri powder After 7~13 basic solvent soaks 10~50h, seepage pressure effects are carried out, obtain percolate, in temperature be 25~100 by percolate Concentrated at DEG C;Step 3:By the mixture after concentration, ultrasound soaks 30~60min in ultrasonic extractor, then in microwave reactor 25~40min of middle heating;Step 4:Mixture after heating is cooled down into 30~50min;Step 5:Mixture after cooling is used Ethanol water is dissolved, and macroporous resin adsorption post on lysate, is washed with water to neutrality, collection is washed buck elution removal of impurities De- liquid;Step 6:Eluent is filtered, obtains saikoside powder after drying.This method does not pass through cell due to radix bupleuri Broken wall, it is therefore desirable to seepage pressure effects, extraction effect are carried out after radix bupleuri powder is soaked into 10~50h with the basic solvent that pH value is 7~13 Rate is low, and the production cycle is long
Therefore, a kind of then method that radix bupleuri breaking-wall cell is first extracted to saikoside is developed, uses relatively mild extraction conditions With nontoxic Extraction solvent, not only contribute to improve the production efficiency of saikoside, and saikoside can be ensured as natural The security of extract.
The content of the invention
The present invention seeks to overcome to need high temperature distillation in the prior art and using more toxic organic solvents extraction bavin A kind of deficiency of Hu saponin(e, there is provided method that saikoside is extracted from radix bupleuri.
To achieve the above object, the present invention uses following technical scheme:
A kind of method that saikoside is extracted from radix bupleuri, comprises the following steps:
(1)Fresh radix bupleuri root is cleaned, section, it is 8% ~ 12% to be dried to water content, obtains radix bupleuri medicine materical crude slice;This water content is advantageous to Improve the broken wall efficiency of wall-breaking machine;
(2)Radix bupleuri medicine materical crude slice is put into -196 DEG C of liquid nitrogen 1 ~ 3 min of freezing, rapid take out is put into wall-breaking machine, with 20000 ~ 40000 rpm rotating speed carries out the min of broken wall treatment 1 ~ 3, obtains the radix bupleuri powder of a broken wall;Wall-breaking machine is once under the conditions of this Broken wall efficiency highest, up to 42 ~ 48%;
(3)The radix bupleuri powder of broken wall is adjusted into water content to 3% ~ 5%, -60 ~ -80 DEG C is refrigerated to, is cut with high pressure purified air Pulverizer carries out secondary broken wall, and air pressure is 100 ~ 200 mPa, and air velocity is 600 ~ 800 m/s, and charging rate is 6 ~ 10 G/s, feed cycle are 2-5 s, and feed pressure is 0.2 ~ 0.3 mPa, obtains the radix bupleuri powder of secondary broken wall;It is secondary broken under the conditions of this Wall efficiency highest, up to 97.1 ~ 99.4%;
(4)By the radix bupleuri powder of secondary broken wall, 2-5 mol/L sodium acetate solution and absolute ethyl alcohol according to 1:3~5:6 ~ 15 quality Than mixing, 15 ~ 45 min are stirred at 40-60 DEG C, 30 ~ 60 min are then stood at 0 ~ 4 DEG C, then 10000 at 0 ~ 4 DEG C ~ 15000 rpm centrifuge 10 ~ 30 min, take supernatant liquor, obtain saikoside crude extract;The extraction of saikoside under the conditions of this The impurity-eliminating effect of efficiency highest, protein and nucleic acid is best;
(5)Saikoside crude extract is refined with preparative high performance liquid chromatography instrument, chromatographic column is C18 reverse phase silica gel colors Post is composed, packing material size is 5 μm, and internal diameter is 7.8 mm, and length is 300 ~ 350 mm, and elution requirement is:0 ~ 10 min is 100% pair Water is steamed, 10-20 min are volume ratio 10% ~ 20%:80% ~ 90% absolute ethyl alcohol and distilled water, 20-30 min be volume ratio 30% ~ 40%:60% ~ 70% absolute ethyl alcohol and distilled water, 30-40 min are volume ratio 50% ~ 60%:40% ~ 50% absolute ethyl alcohol and double Water is steamed, 40-50 min are volume ratio 70% ~ 80%:20% ~ 30% absolute ethyl alcohol and distilled water, 50-60 min be 100% it is anhydrous Ethanol, eluent flow rate are 0.6 ~ 1 mL/min, and the elution composition containing saikoside is reclaimed, obtains refined saikoside Eluent;Separation of saikoside and preparation effect are best under the conditions of this;
(6)Refined saikoside eluent is carried out into vacuum refrigeration under the conditions of -10 ~ -30 DEG C, -0.08 ~ -0.1 MPa to do It is dry, obtain saikoside powder.
Preferably, step(1)In, the section is that radix bupleuri root is cut into the thin slice that thickness is 0.5 ~ 2 mm, this thickness Radix bupleuri root thin slice is advantageous to wall-breaking machine broken wall.
Preferably, step(1)In, it is 9% to be dried to water content, this Water Content Conditions broken wall efficiency highest next time, is reached 48%。
Preferably, step(2)In, radix bupleuri medicine materical crude slice is put into -196 DEG C of liquid nitrogen and freezes 2 min, rapid take out is put into brokenly Wall machine, the min of broken wall treatment 2 is carried out with 30000 rpm rotating speed, this contains condition broken wall efficiency highest next time, up to 48%.
Preferably, step(3)In, the radix bupleuri powder of a broken wall is adjusted into water content to 3%, -75 DEG C is refrigerated to, uses high pressure Purified air cutting mill carries out secondary broken wall, and air pressure is 150 mPa, and air velocity is 700 m/s, and charging rate is 8 g/s, feed cycle are 3 s, and feed pressure is 0.2 mPa, secondary broken wall efficiency highest under the conditions of this, up to 99.4%.
Preferably, step(4)In, by the radix bupleuri powder of secondary broken wall, 3 mol/L sodium acetate solution and absolute ethyl alcohol according to 1:5:10 mass ratio mixing, 40 min are stirred at 55 DEG C, 40 min are then stood at 4 DEG C, then 12000 at 4 DEG C Rpm centrifuges 20 min, the extraction efficiency highest of saikoside under the conditions of this, up to more than 92%, the impurity-eliminating effect of protein and nucleic acid Preferably, more than 95% protein and more than 90% nucleic acid can be removed.
Preferably, step(5)In, described elution requirement is:0 ~ 10 min is 100% distilled water, and 10-20 min are body Product ratio 15%:85% absolute ethyl alcohol and distilled water, 20-30 min are volume ratio 35%:65% absolute ethyl alcohol and distilled water, 30- 40 min are volume ratio 55%:45% absolute ethyl alcohol and distilled water, 40-50 min are volume ratio 75%:25% absolute ethyl alcohol and Distilled water, 50-60 min are 100% absolute ethyl alcohol, and eluent flow rate is 1.2 mL/min, point of saikoside under the conditions of this It is high and sharp from best, the eluting peak distinct of each saikoside, peak type with preparation effect.
Preferably, step(6)In, refined saikoside eluent is subjected to vacuum under the conditions of -20 DEG C, -0.1 MPa Freeze-drying.
The present invention possesses the advantages of following and good effect:
(1)Using the cell progress broken wall of radix bupleuri is first extracted into the technique of saikoside again, cell-wall breaking ratio is up to the present invention 99.4%, saikoside recovery rate is up to more than 92%.
(2)The present invention uses low temperature broken wall and gentle extracting method, can effectively avoid the chemical constitution of saikoside from occurring Change, ensure the good pharmaceutical activity of saikoside.
(3)The present invention prepares saikoside using gradient elution mode separation, good separating effect, it is high to prepare purity.
(4)Whole process of the invention does not add poisonous harmful chemical agents, and the saikoside of extraction is safe.
(5)Present invention process is simple, with short production cycle, workable, is adapted to a large amount of extractions and preparation of saikoside.
Embodiment
Below in conjunction with a kind of method that saikoside is extracted from radix bupleuri of the example description present invention, these descriptions are not pair The restriction of present invention.
Embodiment 1
A kind of method that saikoside is extracted from radix bupleuri, comprises the following steps:
(1)Fresh radix bupleuri root is cleaned, is cut into the thin slice that thickness is 1 mm, it is 9% to be dried to water content, obtains radix bupleuri medicine materical crude slice;
(2)Radix bupleuri medicine materical crude slice is put into -196 DEG C of liquid nitrogen and freezes 2 min, rapid take out is put into wall-breaking machine, with 30000 rpm's Rotating speed carries out the min of broken wall treatment 2, obtains the radix bupleuri powder of a broken wall, sporoderm-broken rate 48%;
(3)The radix bupleuri powder of broken wall is adjusted into water content to 3%, -75 DEG C are refrigerated to, with high pressure purified air cutting mill Carry out secondary broken wall, air pressure is 150 mPa, and air velocity is 700 m/s, and charging rate is 8 g/s, feed cycle 3 S, feed pressure are 0.2 mPa, obtain the radix bupleuri powder of secondary broken wall, sporoderm-broken rate 99.4%;
(4)By the radix bupleuri powder of secondary broken wall, 3 mol/L sodium acetate solution and absolute ethyl alcohol according to 1:5:10 mass ratio mixes Close, 40 min are stirred at 55 DEG C, 40 min are then stood at 4 DEG C, then 12000 rpm centrifuge 20 min at 4 DEG C, take Layer clear liquid, obtains saikoside crude extract;
(5)Saikoside crude extract is refined with preparative high performance liquid chromatography instrument, chromatographic column is C18 reverse phase silica gel colors Post is composed, packing material size is 5 μm, and internal diameter is 7.8 mm, and length is 350 mm, and elution requirement is:0 ~ 10 min is 100% pair of steaming Water, 10-20 min are volume ratio 15%:85% absolute ethyl alcohol and distilled water, 20-30 min are volume ratio 35%:65% it is anhydrous Ethanol and distilled water, 30-40 min are volume ratio 55%:45% absolute ethyl alcohol and distilled water, 40-50 min are volume ratio 75%: 25% absolute ethyl alcohol and distilled water, 50-60 min are 100% absolute ethyl alcohol, and eluent flow rate is 1.2 mL/min, will be contained The elution composition recovery of saikoside, obtains refined saikoside eluent;
(6)Refined saikoside eluent is subjected to vacuum freeze drying under the conditions of -20 DEG C, -0.1 MPa, obtains radix bupleuri Saponin(e powder.
Embodiment 2
A kind of method that saikoside is extracted from radix bupleuri, comprises the following steps:
(1)Fresh radix bupleuri root is cleaned, is cut into the thin slice that thickness is 0.5 mm, it is 12% to be dried to water content, obtains radix bupleuri drink Piece;
(2)Radix bupleuri medicine materical crude slice is put into -196 DEG C of liquid nitrogen and freezes 1 min, rapid take out is put into wall-breaking machine, with 20000 rpm's Rotating speed carries out the min of broken wall treatment 1, obtains the radix bupleuri powder of a broken wall, sporoderm-broken rate 45%;
(3)The radix bupleuri powder of broken wall is adjusted into water content to 5%, -60 DEG C are refrigerated to, with high pressure purified air cutting mill Carry out secondary broken wall, air pressure is 100 mPa, and air velocity is 600 m/s, and charging rate is 10 g/s, feed cycle 2 S, feed pressure are 0.3 mPa, obtain the radix bupleuri powder of secondary broken wall, sporoderm-broken rate 98.6%;
(4)By the radix bupleuri powder of secondary broken wall, 3.5 mol/L sodium acetate solution and absolute ethyl alcohol according to 1:4:10 mass ratio mixes Close, 45 min are stirred at 40 DEG C, 30 min are then stood at 4 DEG C, then 15000 rpm centrifuge 30 min at 4 DEG C, take Layer clear liquid, obtains saikoside crude extract;
(5)Saikoside crude extract is refined with preparative high performance liquid chromatography instrument, chromatographic column is C18 reverse phase silica gel colors Post is composed, packing material size is 5 μm, and internal diameter is 7.8 mm, and length is 300 mm, and elution requirement is:0 ~ 10 min is 100% pair of steaming Water, 10-20 min are volume ratio 10%:90% absolute ethyl alcohol and distilled water, 20-30 min are volume ratio 30%:70% it is anhydrous Ethanol and distilled water, 30-40 min are volume ratio 50%:50% absolute ethyl alcohol and distilled water, 40-50 min are volume ratio 70%%:30% absolute ethyl alcohol and distilled water, 50-60 min are 100% absolute ethyl alcohol, and eluent flow rate is 1 mL/min, will Elution composition recovery containing saikoside, obtains refined saikoside eluent;
(6)Refined saikoside eluent is subjected to vacuum freeze drying under the conditions of -10 DEG C, -0.1 MPa, obtains radix bupleuri Saponin(e powder.
Embodiment 3
A kind of method that saikoside is extracted from radix bupleuri, comprises the following steps:
(1)Fresh radix bupleuri root is cleaned, is cut into the thin slice that thickness is 2 mm, it is 8% to be dried to water content, obtains radix bupleuri medicine materical crude slice;
(2)Radix bupleuri medicine materical crude slice is put into -196 DEG C of liquid nitrogen and freezes 2 min, rapid take out is put into wall-breaking machine, with 40000rpm's Rotating speed carries out the min of broken wall treatment 2, obtains the radix bupleuri powder of a broken wall, sporoderm-broken rate 44%;
(3)The radix bupleuri powder of broken wall is adjusted into water content to 4%, -80 DEG C are refrigerated to, with high pressure purified air cutting mill Carry out secondary broken wall, air pressure is 180 mPa, and air velocity is 800 m/s, and charging rate is 6 g/s, feed cycle 2 S, feed pressure are 0.3 mPa, obtain the radix bupleuri powder of secondary broken wall, sporoderm-broken rate 99.0%;
(4)By the radix bupleuri powder of secondary broken wall, 4 mol/L sodium acetate solution and absolute ethyl alcohol according to 1: 3:10 mass ratio mixes Close, 15 min are stirred at 60 DEG C, 30 min are then stood at 0 DEG C, then 15000 rpm centrifuge 10 min at 0 DEG C, take Layer clear liquid, obtains saikoside crude extract;
(5)Saikoside crude extract is refined with preparative high performance liquid chromatography instrument, chromatographic column is C18 reverse phase silica gel colors Post is composed, packing material size is 5 μm, and internal diameter is 7.8 mm, and length is 350 mm, and elution requirement is:0 ~ 10 min is 100% pair of steaming Water, 10-20 min are volume ratio 15%:85% absolute ethyl alcohol and distilled water, 20-30 min are volume ratio 35%:65% it is anhydrous Ethanol and distilled water, 30-40 min are volume ratio 55%:45% absolute ethyl alcohol and distilled water, 40-50 min are volume ratio 75%: 25% absolute ethyl alcohol and distilled water, 50-60 min are 100% absolute ethyl alcohol, eluent flow rate 0.8mL/min, will be contained The elution composition recovery of saikoside, obtains refined saikoside eluent;
(6)Refined saikoside eluent is subjected to vacuum freeze drying under the conditions of -30 DEG C, -0.08 MPa, obtains radix bupleuri Saponin(e powder.
Embodiment 4
A kind of method that saikoside is extracted from radix bupleuri, comprises the following steps:
(1)Fresh radix bupleuri root is cleaned, is cut into the thin slice that thickness is 1.5 mm, it is 12% to be dried to water content, obtains radix bupleuri drink Piece;
(2)Radix bupleuri medicine materical crude slice is put into -196 DEG C of liquid nitrogen and freezes 3 min, rapid take out is put into wall-breaking machine, with 20000 rpm's Rotating speed carries out the min of broken wall treatment 3, obtains the radix bupleuri powder of a broken wall, sporoderm-broken rate 42%;
(3)The radix bupleuri powder of broken wall is adjusted into water content to 5%, -75 DEG C are refrigerated to, with high pressure purified air cutting mill Carry out secondary broken wall, air pressure is 150 mPa, and air velocity is 650 m/s, and charging rate is 9 g/s, feed cycle 4 S, feed pressure are 0.3 mPa, obtain the radix bupleuri powder of secondary broken wall, sporoderm-broken rate 97.1%;
(4)By the radix bupleuri powder of secondary broken wall, 2 mol/L sodium acetate solution and absolute ethyl alcohol according to 1:4:8 mass ratio mixing, 45 min are stirred at 55 DEG C, 60 min are then stood at 2 DEG C, then 12000 rpm centrifuge 10 min at 2 DEG C, take upper strata Clear liquid, obtain saikoside crude extract;
(5)Saikoside crude extract is refined with preparative high performance liquid chromatography instrument, chromatographic column is C18 reverse phase silica gel colors Post is composed, packing material size is 5 μm, and internal diameter is 7.8 mm, and length is 350 mm, and elution requirement is:0 ~ 10 min is 100% pair of steaming Water, 10-20 min are volume ratio 20%:80% absolute ethyl alcohol and distilled water, 20-30 min are volume ratio 40%:60% it is anhydrous Ethanol and distilled water, 30-40 min are volume ratio 60%:40% absolute ethyl alcohol and distilled water, 40-50 min are volume ratio 80%: 20% absolute ethyl alcohol and distilled water, 50-60 min are 100% absolute ethyl alcohol, and eluent flow rate is 0.6 mL/min, will be contained The elution composition recovery of saikoside, obtains refined saikoside eluent;
(6)Refined saikoside eluent is subjected to vacuum freeze drying under the conditions of -25 DEG C, -0.09 MPa, obtains radix bupleuri Saponin(e powder.

Claims (8)

  1. A kind of 1. method that saikoside is extracted from radix bupleuri, it is characterised in that comprise the following steps:
    (1)Fresh radix bupleuri root is cleaned, section, it is 8% ~ 12% to be dried to water content, obtains radix bupleuri medicine materical crude slice;
    (2)Radix bupleuri medicine materical crude slice is put into -196 DEG C of liquid nitrogen 1 ~ 3 min of freezing, rapid take out is put into wall-breaking machine, with 20000 ~ 40000 rpm rotating speed carries out the min of broken wall treatment 1 ~ 3, obtains the radix bupleuri powder of a broken wall;
    (3)The radix bupleuri powder of broken wall is adjusted into water content to 3% ~ 5%, -60 ~ -80 DEG C is refrigerated to, is cut with high pressure purified air Pulverizer carries out secondary broken wall, and air pressure is 100 ~ 200 mPa, and air velocity is 600 ~ 800 m/s, and charging rate is 6 ~ 10 G/s, feed cycle are 2-5 s, and feed pressure is 0.2 ~ 0.3 mPa, obtains the radix bupleuri powder of secondary broken wall;
    (4)By the radix bupleuri powder of secondary broken wall, 2-5 mol/L sodium acetate solution and absolute ethyl alcohol according to 1:3~5:6 ~ 15 quality Than mixing, 15 ~ 45 min are stirred at 40-60 DEG C, 30 ~ 60 min are then stood at 0 ~ 4 DEG C, then 10000 at 0 ~ 4 DEG C ~ 15000 rpm centrifuge 10 ~ 30 min, take supernatant liquor, obtain saikoside crude extract;
    (5)Saikoside crude extract is refined with preparative high performance liquid chromatography instrument, chromatographic column is C18 reverse phase silica gel colors Post is composed, packing material size is 5 μm, and internal diameter is 7.8 mm, and length is 300 ~ 350 mm, and elution requirement is:0 ~ 10 min is 100% pair Water is steamed, 10-20 min are volume ratio 10% ~ 20%:80% ~ 90% absolute ethyl alcohol and distilled water, 20-30 min be volume ratio 30% ~ 40%:60% ~ 70% absolute ethyl alcohol and distilled water, 30-40 min are volume ratio 50% ~ 60%:40% ~ 50% absolute ethyl alcohol and double Water is steamed, 40-50 min are volume ratio 70% ~ 80%:20% ~ 30% absolute ethyl alcohol and distilled water, 50-60 min be 100% it is anhydrous Ethanol, eluent flow rate are 1 ~ 2 mL/min, and the elution composition containing saikoside is reclaimed, refined saikoside is obtained and washes De- liquid;
    (6)Refined saikoside eluent is carried out into vacuum refrigeration under the conditions of -10 ~ -30 DEG C, -0.08 ~ -0.1 MPa to do It is dry, obtain saikoside powder.
  2. 2. the method according to claim 1 that saikoside is extracted from radix bupleuri, it is characterised in that step(1)In, it is described Cut into slices as radix bupleuri root is cut into the thin slice that thickness is 0.5 ~ 2 mm.
  3. 3. the method according to claim 2 that saikoside is extracted from radix bupleuri, it is characterised in that step(1)In, dry It is 9% to water content.
  4. 4. the method according to claim 1 that saikoside is extracted from radix bupleuri, it is characterised in that step(2)In, by bavin Hu medicine materical crude slice, which is put into -196 DEG C of liquid nitrogen, freezes 2 min, and rapid take out is put into wall-breaking machine, is broken with 30000 rpm rotating speed Wall handles 2 min.
  5. 5. the method according to claim 1 that saikoside is extracted from radix bupleuri, it is characterised in that step(3)In, by one The radix bupleuri powder of secondary broken wall adjusts water content to 3%, is refrigerated to -75 DEG C, is carried out with high pressure purified air cutting mill secondary broken Wall, air pressure are 150 mPa, and air velocity is 700 m/s, and charging rate is 8 g/s, and feed cycle is 3 s, feed pressure For 0.2 mPa.
  6. 6. the method according to claim 1 that saikoside is extracted from radix bupleuri, it is characterised in that step(4)In, by two The radix bupleuri powder of secondary broken wall, 3 mol/L sodium acetate solution and absolute ethyl alcohol are according to 1:5:10 mass ratio mixing, is stirred at 55 DEG C 40 min are mixed, 40 min are then stood at 4 DEG C, then 12000 rpm centrifuge 20 min at 4 DEG C.
  7. 7. the method according to claim 1 that saikoside is extracted from radix bupleuri, it is characterised in that step(5)In, it is described Elution requirement be:0 ~ 10 min is 100% distilled water, and 10-20 min are volume ratio 15%:85% absolute ethyl alcohol and distilled water, 20-30 min are volume ratio 35%:65% absolute ethyl alcohol and distilled water, 30-40 min are volume ratio 55%:45% absolute ethyl alcohol And distilled water, 40-50 min are volume ratio 75%:25% absolute ethyl alcohol and distilled water, 50-60 min are 100% anhydrous second Alcohol, eluent flow rate are 1.2 mL/min.
  8. 8. the method according to claim 1 that saikoside is extracted from radix bupleuri, it is characterised in that step(6)In, by essence The saikoside eluent of system carries out vacuum freeze drying under the conditions of -20 DEG C, -0.1 MPa.
CN201711146228.1A 2017-11-17 2017-11-17 A kind of method that saikoside is extracted from radix bupleuri Pending CN107812021A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201711146228.1A CN107812021A (en) 2017-11-17 2017-11-17 A kind of method that saikoside is extracted from radix bupleuri

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201711146228.1A CN107812021A (en) 2017-11-17 2017-11-17 A kind of method that saikoside is extracted from radix bupleuri

Publications (1)

Publication Number Publication Date
CN107812021A true CN107812021A (en) 2018-03-20

Family

ID=61609401

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201711146228.1A Pending CN107812021A (en) 2017-11-17 2017-11-17 A kind of method that saikoside is extracted from radix bupleuri

Country Status (1)

Country Link
CN (1) CN107812021A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109363027A (en) * 2018-10-22 2019-02-22 蓝妙田 The preparation method of mango beverage

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101757553A (en) * 2008-12-04 2010-06-30 郑州豫密药业股份有限公司 Method for preparing depression alleviating pills
CN102659903A (en) * 2012-05-10 2012-09-12 青川德康源药业有限公司 Method for extracting and purifying Chinese thorowax root saponin a or Chinese thorowax root saponin d
CN104127491A (en) * 2014-07-29 2014-11-05 成都乾坤动物药业有限公司 Pharmaceutical composition with fever relieving effect and preparation method and application thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101757553A (en) * 2008-12-04 2010-06-30 郑州豫密药业股份有限公司 Method for preparing depression alleviating pills
CN102659903A (en) * 2012-05-10 2012-09-12 青川德康源药业有限公司 Method for extracting and purifying Chinese thorowax root saponin a or Chinese thorowax root saponin d
CN104127491A (en) * 2014-07-29 2014-11-05 成都乾坤动物药业有限公司 Pharmaceutical composition with fever relieving effect and preparation method and application thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
高立超等: "《仲景源中医食方食品丛书 药食同源本草素食方库》", 30 June 2016, 上海科学技术文献出版社 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109363027A (en) * 2018-10-22 2019-02-22 蓝妙田 The preparation method of mango beverage

Similar Documents

Publication Publication Date Title
CN102746362A (en) Method for extracting refined astragaloside from astragaliradix
CN103948659A (en) Preparation method of notoginseng leaf total saponins
CN105998103B (en) Chestnut flower activity extract and its preparation method and application
CN110818585B (en) Separation method for simultaneously preparing five dopamine compounds from aspongopus
CN103739586A (en) Method for extracting diterpenoid compounds from Blumea aromatic DC.
CN105132172A (en) Method for preparing orris root flavonoid matter for tobaccos from orris roots
CN109879919B (en) Method for separating and preparing three flavonoid glycosides from spina date seeds
CN108164579A (en) A kind of method of aerial part extraction separation chonglou saponin H from Paris polyphylla
CN113264974B (en) Preparation of type B cardiac glycoside and anti-angiogenesis application thereof
CN107298642B (en) Extraction and purification method of 6-shogaol
CN103665065B (en) A kind of method of preparing fast ponticin and rhapontigenin
CN105175426B (en) A kind of method of the extraction purification Bergenin from treebine stem
CN107812021A (en) A kind of method that saikoside is extracted from radix bupleuri
CN101880301B (en) Novel method for preparing paeoniflorin extract
Hou et al. Preparative purification of corilagin from Phyllanthus by combining ionic liquid extraction, prep-HPLC, and precipitation
CN102670935B (en) Method for extracting total saponins from allium chinense
CN106674239B (en) A kind of Viburnum opulus Linn. var. calvescens (Rehd.) Hara f. calvescens branches and leaves lignanoid and extracting method and purposes
CN102526134A (en) Preparation method of dipsacus total saponins and teasel saponins VI
CN104892714A (en) New ganoderma lucidum triterpene, preparation method and medicinal uses thereof
CN111329866B (en) Application of pentacyclic triterpenoid in preparation of anti-migraine medicine
CN107629106A (en) A kind of method that notoginsenoside is extracted from pseudo-ginseng
CN104151390A (en) Method for separating and preparing ursolic acid methyl ester from dracocephalum heterophyllum benth and application of ursolic acid methyl ester
CN113248483A (en) Preparation method and application of lawn pennywort herb flavone glycoside monomer isovitexin
CN111592537A (en) Sinomenium majus indole alkaloid for reducing hyperuricemia and application thereof
CN108727441A (en) A kind of extracting method of rhodioside

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20180320

RJ01 Rejection of invention patent application after publication